Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
Arachchillage DR, Laffan M, 2017, Pathogenesis and management of antiphospholipid syndrome., Br J Haematol
et al., 2017, Thromboelastography (TEG (R)) demonstrates that tinzaparin 4500 international units has no detectable anticoagulant activity after caesarean section, International Journal of Obstetric Anesthesia, Vol:29, ISSN:0959-289X, Pages:50-56
et al., 2017, ADAMTS-13 glycans and conformation-dependent activity., J Thromb Haemost
Randi AM, Laffan MA, 2017, Von Willebrand factor and angiogenesis: basic and applied issues, Journal of Thrombosis and Haemostasis, Vol:15, ISSN:1538-7933, Pages:13-20
et al., 2017, Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia, Blood, Vol:129, ISSN:0006-4971, Pages:520-524